Category Archives: healthcare

Will the Supreme Court Spur OTC Contraceptive Development?

One piece of fall-out from the recent Hobby Lobby decision by the U.S. Supreme Court is to generate talk of Republicans backing development of a nonprescription contraceptive pill. Conservative commentators supported this strategy as a way for Republicans to deflect Democratic charges of a GOP “war on women” and access to safe and effective birth […]
Also posted in FDA, Op-Ed, Regulatory | Tagged , , | 1 Comment

435 New Medicines in Development for “Older Americans”

By Melanie Sena. According to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA), America’s biopharmaceutical research companies are developing 435 new medicines to target 15 leading chronic conditions affecting the Medicare population. These medicines in development include: 110 for diabetes, 62 for rheumatoid arthritis and osteoarthritis, 67 for Alzheimer’s disease, 61 […]
Also posted in R&D | Tagged , , , , | Leave a comment

Q&A: Gauging Impact of Comparative Effectiveness Research

While at DIA’s 50th Annual Meeting, we got the chance to speak with Nancy Dreyer, chief of scientific affairs and senior VP at Quintiles Outcome, the CRO’s real-world and late-phase research division, about the current tide for comparative effectiveness research (CER). Dreyer is the leader of the GRACE Initiative, which has developed good practice principles for […]
Also posted in comparative effectiveness, Global, Regulatory, Uncategorized | Tagged , , , , , | Leave a comment

Abrams Talks Social Media at DIA

“It doesn’t turn me on to send a warning letter.” –Tom Abrams, during a Q&A at DIA.  Instead of repeating his yearly Drug Information Association (DIA) conference claim that social media guidance remains among the FDA’s Office of Prescription Drug Promotion’s (OPDP) “highest priorities,” to be published in due course, Tom Abrams, director of OPDP, […]
Also posted in Advertising, E-Media, FDA, Legal, Marketing, Meetings, Patient Communication, Regulatory, social media, Strategy, Technology | Tagged , , , , , | Leave a comment

Social Media Questions Pharma Companies Should Be Asking

For pharma companies, entering the social media scene is not as simple as just creating a Facebook page or learning how to tweet in 140 characters or less. Social media poses a regulatory and litigation maze that must be carefully navigated. Here, Mathew dos Santos and Lori Leskin provide some insight into the most pressing questions companies are, […]
Also posted in E-Media, FDA, Guest Blog, multimedia, Patient Communication, Regulatory, social media | Tagged , , | Leave a comment
  • Categories

  • Meta